Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer

(2019) Cristina Müller et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile

(2018) Martina Benešová et al.   MOLECULAR PHARMACEUTICS

44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617

(2017) Christoph A. Umbricht et al.   EJNMMI Research

Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy

(2016) E. Hindie et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison between Three Promising ß-emitting Radionuclides, 67Cu, 47Sc and 161Tb, with Emphasis on Doses Delivered to Minimal Residual Disease

(2016) Christophe Champion et al.   Theranostics

Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging

(2016) Cristina Müller et al.   EJNMMI Research

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate

(2016) Stephanie Haller et al.   EJNMMI Research

Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate

(2013) Cristina Müller et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice

(2013) Cristina Müller et al.   NUCLEAR MEDICINE AND BIOLOGY

A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for  - and  --Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative

(2012) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

(2011) Silvia Lehenberger et al.   NUCLEAR MEDICINE AND BIOLOGY